ID   HeLa/Blvra KO
AC   CVCL_D5I9
SY   BLVRA KO HeLa
DR   JCRB; JCRB1992
DR   Wikidata; Q127381702
RX   PubMed=29078307;
RX   PubMed=32581154;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1062; BLVRA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1992
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
RX   PubMed=29078307; DOI=10.1073/pnas.1707190114; PMCID=PMC5692546;
RA   Uda Y., Goto Y., Oda S., Kohchi T., Matsuda M., Aoki K.;
RT   "Efficient synthesis of phycocyanobilin in mammalian cells for
RT   optogenetic control of cell signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:11962-11967(2017).
//
RX   PubMed=32581154; DOI=10.1247/csf.20010; PMCID=PMC10511041;
RA   Kobachi K., Kuno S., Sato S., Sumiyama K., Matsuda M., Terai K.;
RT   "Biliverdin reductase-A deficiency brighten and sensitize
RT   biliverdin-binding chromoproteins.";
RL   Cell Struct. Funct. 45:131-141(2020).
//